Novasep, a supplier of services and technologies for the life sciences industry, is investing $7.3 million at its Mourenx site in France to modernize the API manufacturing facility.   Upgrades to this cGMP workshop include the installation of new equipment and the revamping of clean rooms for API isolation. This project will enhance Novasep’s flexibility and develop a high-performance capacity for the custom manufacturing of innovative therapeutic molecules, in accordance with the highest qualit...